25 XP   0   0   10

Heron Therapeuti
Buy, Hold or Sell?

Let's analyze Heron Therapeuti together

I guess you are interested in Heron Therapeuti. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Heron Therapeuti. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Heron Therapeuti

I send you an email if I find something interesting about Heron Therapeuti.

Quick analysis of Heron Therapeuti (30 sec.)










What can you expect buying and holding a share of Heron Therapeuti? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$-0.22
Expected worth in 1 year
$-0.37
How sure are you?
25.0%

+ What do you gain per year?

Total Gains per Share
$-0.15
Return On Investment
-5.3%

For what price can you sell your share?

Current Price per Share
$2.77
Expected price per share
$2.16 - $4.15
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Heron Therapeuti (5 min.)




Live pricePrice per Share (EOD)

$2.77

Intrinsic Value Per Share

$-6.33 - $5.09

Total Value Per Share

$-6.56 - $4.86

2. Growth of Heron Therapeuti (5 min.)




Is Heron Therapeuti growing?

Current yearPrevious yearGrowGrow %
How rich?-$33.7m$714.2k-$34.4m-102.1%

How much money is Heron Therapeuti making?

Current yearPrevious yearGrowGrow %
Making money-$20.2m-$41.2m$20.9m103.6%
Net Profit Margin-63.1%-146.7%--

How much money comes from the company's main activities?

3. Financial Health of Heron Therapeuti (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#933 / 966

Most Revenue
#163 / 966

Most Profit
#702 / 966

Most Efficient
#424 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Heron Therapeuti? (5 min.)

Welcome investor! Heron Therapeuti's management wants to use your money to grow the business. In return you get a share of Heron Therapeuti.

What can you expect buying and holding a share of Heron Therapeuti?

First you should know what it really means to hold a share of Heron Therapeuti. And how you can make/lose money.

Speculation

The Price per Share of Heron Therapeuti is $2.77. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Heron Therapeuti.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Heron Therapeuti, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.22. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Heron Therapeuti.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.02-0.8%-0.13-4.8%-0.25-9.0%-0.29-10.6%-0.27-9.9%
Usd Book Value Change Per Share0.000.1%-0.04-1.3%-0.06-2.1%-0.12-4.4%-0.01-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.062.0%
Usd Total Gains Per Share0.000.1%-0.04-1.3%-0.06-2.1%-0.12-4.4%0.041.5%
Usd Price Per Share2.77-1.67-2.76-9.90-15.11-
Price to Earnings Ratio-33.13--10.42--3.03--9.17--15.63-
Price-to-Total Gains Ratio1,268.67-308.62--11.58-26.64--20.66-
Price to Book Ratio-12.40--7.49-4.21-7.10-17.29-
Price-to-Total Gains Ratio1,268.67-308.62--11.58-26.64--20.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.77
Number of shares361
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.04-0.12
Usd Total Gains Per Share-0.04-0.12
Gains per Quarter (361 shares)-13.31-43.79
Gains per Year (361 shares)-53.23-175.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-53-630-175-185
20-106-1160-350-360
30-160-1690-525-535
40-213-2220-701-710
50-266-2750-876-885
60-319-3280-1051-1060
70-373-3810-1226-1235
80-426-4340-1401-1410
90-479-4870-1576-1585
100-532-5400-1751-1760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%14.0124.01.010.1%
Book Value Change Per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%9.031.00.022.5%41.098.00.029.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%1.00.0138.00.7%
Total Gains per Share2.02.00.050.0%3.09.00.025.0%4.016.00.020.0%10.030.00.025.0%42.097.00.030.2%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Heron Therapeuti

About Heron Therapeuti

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-06-18 00:11:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Heron Therapeuti.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Heron Therapeuti earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Heron Therapeuti to the Biotechnology industry mean.
  • A Net Profit Margin of -9.1% means that $-0.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Heron Therapeuti:

  • The MRQ is -9.1%. The company is making a loss. -1
  • The TTM is -63.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-63.1%+54.0%
TTM-63.1%YOY-146.7%+83.6%
TTM-63.1%5Y-178.1%+115.0%
5Y-178.1%10Y-472.3%+294.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-168.0%+158.9%
TTM-63.1%-209.9%+146.8%
YOY-146.7%-242.3%+95.6%
5Y-178.1%-401.7%+223.6%
10Y-472.3%-532.2%+59.9%
1.1.2. Return on Assets

Shows how efficient Heron Therapeuti is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Heron Therapeuti to the Biotechnology industry mean.
  • -1.5% Return on Assets means that Heron Therapeuti generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Heron Therapeuti:

  • The MRQ is -1.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -9.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM-9.5%+8.1%
TTM-9.5%YOY-16.7%+7.2%
TTM-9.5%5Y-14.1%+4.6%
5Y-14.1%10Y-20.5%+6.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.5%-11.9%+10.4%
TTM-9.5%-11.9%+2.4%
YOY-16.7%-11.3%-5.4%
5Y-14.1%-13.5%-0.6%
10Y-20.5%-14.9%-5.6%
1.1.3. Return on Equity

Shows how efficient Heron Therapeuti is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Heron Therapeuti to the Biotechnology industry mean.
  • 0.0% Return on Equity means Heron Therapeuti generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Heron Therapeuti:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-96.8%+96.8%
TTM-5Y-47.9%+47.9%
5Y-47.9%10Y-47.2%-0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--15.7%+15.7%
YOY-96.8%-14.3%-82.5%
5Y-47.9%-19.2%-28.7%
10Y-47.2%-19.7%-27.5%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Heron Therapeuti.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Heron Therapeuti is operating .

  • Measures how much profit Heron Therapeuti makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Heron Therapeuti to the Biotechnology industry mean.
  • An Operating Margin of -13.8% means the company generated $-0.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Heron Therapeuti:

  • The MRQ is -13.8%. The company is operating very inefficient. -2
  • The TTM is -64.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-64.1%+50.3%
TTM-64.1%YOY-129.7%+65.6%
TTM-64.1%5Y-175.0%+110.9%
5Y-175.0%10Y-465.3%+290.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.8%-354.6%+340.8%
TTM-64.1%-225.9%+161.8%
YOY-129.7%-252.2%+122.5%
5Y-175.0%-428.3%+253.3%
10Y-465.3%-531.1%+65.8%
1.2.2. Operating Ratio

Measures how efficient Heron Therapeuti is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are $1.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Heron Therapeuti:

  • The MRQ is 1.138. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.641. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.138TTM1.641-0.503
TTM1.641YOY2.291-0.649
TTM1.6415Y2.744-1.103
5Y2.74410Y6.994-4.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1383.004-1.866
TTM1.6413.332-1.691
YOY2.2913.502-1.211
5Y2.7445.271-2.527
10Y6.9946.915+0.079
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Heron Therapeuti.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Heron Therapeuti is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.47 means the company has $2.47 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Heron Therapeuti:

  • The MRQ is 2.466. The company is able to pay all its short-term debts. +1
  • The TTM is 2.293. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.466TTM2.293+0.173
TTM2.293YOY2.235+0.059
TTM2.2935Y3.188-0.895
5Y3.18810Y4.212-1.023
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4663.767-1.301
TTM2.2934.000-1.707
YOY2.2354.905-2.670
5Y3.1885.883-2.695
10Y4.2126.286-2.074
1.3.2. Quick Ratio

Measures if Heron Therapeuti is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Heron Therapeuti to the Biotechnology industry mean.
  • A Quick Ratio of 2.49 means the company can pay off $2.49 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Heron Therapeuti:

  • The MRQ is 2.493. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.177. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.493TTM2.177+0.316
TTM2.177YOY2.079+0.098
TTM2.1775Y3.717-1.541
5Y3.71710Y4.987-1.269
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4933.054-0.561
TTM2.1773.506-1.329
YOY2.0794.756-2.677
5Y3.7175.757-2.040
10Y4.9876.338-1.351
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Heron Therapeuti.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Heron Therapeuti assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Heron Therapeuti to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.15 means that Heron Therapeuti assets are financed with 115.5% credit (debt) and the remaining percentage (100% - 115.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Heron Therapeuti:

  • The MRQ is 1.155. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.156. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.155TTM1.156-0.001
TTM1.156YOY1.001+0.155
TTM1.1565Y0.689+0.467
5Y0.68910Y0.516+0.173
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1550.330+0.825
TTM1.1560.342+0.814
YOY1.0010.287+0.714
5Y0.6890.368+0.321
10Y0.5160.382+0.134
1.4.2. Debt to Equity Ratio

Measures if Heron Therapeuti is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Heron Therapeuti to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Heron Therapeuti:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY7.151-7.151
TTM-5Y2.429-2.429
5Y2.42910Y1.536+0.893
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.365-0.365
TTM-0.415-0.415
YOY7.1510.370+6.781
5Y2.4290.443+1.986
10Y1.5360.476+1.060
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Heron Therapeuti

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Heron Therapeuti generates.

  • Above 15 is considered overpriced but always compare Heron Therapeuti to the Biotechnology industry mean.
  • A PE ratio of -33.13 means the investor is paying $-33.13 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Heron Therapeuti:

  • The EOD is -33.135. Based on the earnings, the company is expensive. -2
  • The MRQ is -33.135. Based on the earnings, the company is expensive. -2
  • The TTM is -10.424. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.135MRQ-33.1350.000
MRQ-33.135TTM-10.424-22.711
TTM-10.424YOY-3.033-7.391
TTM-10.4245Y-9.166-1.258
5Y-9.16610Y-15.634+6.468
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-33.135-2.341-30.794
MRQ-33.135-2.997-30.138
TTM-10.424-2.882-7.542
YOY-3.033-3.553+0.520
5Y-9.166-6.262-2.904
10Y-15.634-6.288-9.346
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Heron Therapeuti:

  • The EOD is -11.003. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -11.003. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 3.138. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-11.003MRQ-11.0030.000
MRQ-11.003TTM3.138-14.141
TTM3.138YOY-3.172+6.310
TTM3.1385Y-8.884+12.022
5Y-8.88410Y-17.344+8.460
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.003-2.932-8.071
MRQ-11.003-3.739-7.264
TTM3.138-3.776+6.914
YOY-3.172-4.917+1.745
5Y-8.884-7.942-0.942
10Y-17.344-8.503-8.841
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Heron Therapeuti is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -12.40 means the investor is paying $-12.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Heron Therapeuti:

  • The EOD is -12.404. Based on the equity, the company is expensive. -2
  • The MRQ is -12.404. Based on the equity, the company is expensive. -2
  • The TTM is -7.494. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-12.404MRQ-12.4040.000
MRQ-12.404TTM-7.494-4.910
TTM-7.494YOY4.207-11.701
TTM-7.4945Y7.104-14.597
5Y7.10410Y17.292-10.188
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.4041.843-14.247
MRQ-12.4042.249-14.653
TTM-7.4942.301-9.795
YOY4.2072.412+1.795
5Y7.1043.782+3.322
10Y17.2924.212+13.080
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Heron Therapeuti.

3.1. Institutions holding Heron Therapeuti

Institutions are holding 80.47% of the shares of Heron Therapeuti.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31Rubric Capital Management LP17.73372.1872671350300
2024-03-31Orbimed Advisors, LLC6.71250.51310111550418295970.5557
2024-03-31Vanguard Group Inc5.38690.00058114716-224196-2.6886
2024-03-31BlackRock Inc4.83680.000572860281236761.7268
2024-03-31Velan Capital Investment Management LP4.63818.7886698674400
2024-03-31Franklin Resources Inc4.23180.00566374584-30211-0.4717
2024-03-31Tejara Capital Ltd2.92864.49034411567-863669-16.3721
2024-03-31Palisade Capital Management LLc2.47760.27283732241861382.3625
2024-03-31Millennium Management LLC2.10260.003831672861930129156.0133
2024-03-31Adage Capital Partners Gp LLC1.93180.0152291001100
2024-03-31Geode Capital Management, LLC1.85620.000727961191714456.532
2024-03-31Clearline Capital LP1.8430.37532776204-3292350-54.2526
2024-03-31D. E. Shaw & Co LP1.78910.006426950462449773998.7944
2024-03-31State Street Corporation1.62040.00032440870-40975-1.651
2024-03-31Renaissance Technologies Corp1.59750.0105240648652318627.7803
2024-03-31JW Asset Management, LLC1.52182.3197229241800
2024-03-31Orchard Capital Management, Llc1.50821.84582271883284571.2685
2024-03-31TANG CAPITAL MANAGEMENT LLC1.22810.5336185000000
2024-03-31Monaco Asset Management1.20371.50321813164-413311-18.5635
2024-03-31Congress Park Capital LLC1.09192.01641644785-153865-8.5545
Total 68.240324.8892102795205+4477186+4.4%

3.2. Funds holding Heron Therapeuti

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv3.77660.00095689000138108432.0592
2024-02-29Biotech Growth Ord3.49532.9828526520000
2024-04-30Franklin Biotechnology Discv A(acc)USD2.1090.4526317691700
2024-05-30iShares Russell 2000 ETF1.6050.01412417697183920.7666
2024-03-31Palisade Small Cap Core Equity1.520.42292289680-19072-0.8261
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr1.46270.00522203416-433-0.0196
2024-02-29Orchard Select Small Cap Value1.33971.7312201812619865666294.5691
2024-02-29Orchard US Small Cap Value USD Instl 11.33971.7312201812600
2024-02-29Orchard Small Cap Value ESG1.33971.7312201812600
2024-04-30Franklin Small Cap Growth Adv1.19330.1493179760800
2024-03-31Franklin US Small Cap Growth Equity1.19330.1682179760800
2024-03-31Franklin Small Cap Growth SMA1.19330.1682179760817975151932811.828
2024-04-30Franklin Biotechnology Discovery A0.79350.317119537700
2024-03-31Fidelity Small Cap Index0.68020.01061024675-27484-2.6122
2024-04-30Fidelity Extended Market Index0.56680.0054853744-7737-0.8981
2024-05-31State St Russell Sm/Mid Cp® Indx NL Cl C0.53920.007281216000
2024-05-30iShares Russell 2000 Growth ETF0.53720.025580923000
2024-05-31Schwab US Small-Cap ETF™0.47180.014871070500
2024-05-31State Street Instl Small-Cap Equity Inv0.39680.21865976835586410.3105
2024-04-30Nuveen Equity Index R60.28720.002343267100
Total 25.840310.159238925357+5184695+13.3%

3.3. Insider Transactions

Insiders are holding 0.701% of the shares of Heron Therapeuti.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-16Craig A CollardBUY1500000.92
2023-11-16Ira DuarteBUY850000.89
2023-11-16William P ForbesBUY500000.94
2023-07-21Adam MorganBUY24867441.37
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Heron Therapeuti compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.002-0.037+1788%-0.059+2790%-0.121+5655%-0.015+777%
Book Value Per Share---0.223-0.224+0%0.005-4810%0.877-125%0.908-125%
Current Ratio--2.4662.293+8%2.235+10%3.188-23%4.212-41%
Debt To Asset Ratio--1.1551.1560%1.001+15%0.689+68%0.516+124%
Debt To Equity Ratio----0%7.151-100%2.429-100%1.536-100%
Dividend Per Share----0%-0%-0%0.056-100%
Eps---0.021-0.134+543%-0.250+1098%-0.294+1306%-0.275+1214%
Free Cash Flow Per Share---0.063-0.074+18%-0.214+240%-0.231+268%-0.230+265%
Free Cash Flow To Equity Per Share---0.0630.016-493%-0.089+41%-0.074+18%0.001-10198%
Gross Profit Margin--4.6212.448+89%1.526+203%1.616+186%1.413+227%
Intrinsic Value_10Y_max--5.088--------
Intrinsic Value_10Y_min---6.333--------
Intrinsic Value_1Y_max---0.650--------
Intrinsic Value_1Y_min---0.877--------
Intrinsic Value_3Y_max---1.070--------
Intrinsic Value_3Y_min---2.440--------
Intrinsic Value_5Y_max---0.423--------
Intrinsic Value_5Y_min---3.778--------
Market Cap417308787.8400%418821230.000251215342.220+67%415048992.960+1%1491351926.668-72%2276574004.790-82%
Net Profit Margin---0.091-0.631+592%-1.467+1510%-1.781+1854%-4.723+5081%
Operating Margin---0.138-0.641+363%-1.297+837%-1.750+1164%-4.653+3262%
Operating Ratio--1.1381.641-31%2.291-50%2.744-59%6.994-84%
Pb Ratio-12.4040%-12.404-7.494-40%4.207-395%7.104-275%17.292-172%
Pe Ratio-33.1350%-33.135-10.424-69%-3.033-91%-9.166-72%-15.634-53%
Price Per Share2.7700%2.7701.665+66%2.755+1%9.899-72%15.111-82%
Price To Free Cash Flow Ratio-11.0030%-11.0033.138-451%-3.172-71%-8.884-19%-17.344+58%
Price To Total Gains Ratio1268.6690%1268.669308.624+311%-11.583+101%26.641+4662%-20.655+102%
Quick Ratio--2.4932.177+15%2.079+20%3.717-33%4.987-50%
Return On Assets---0.015-0.095+556%-0.167+1053%-0.141+871%-0.205+1313%
Return On Equity----0%-0.9680%-0.4790%-0.4720%
Total Gains Per Share--0.002-0.037+1788%-0.059+2790%-0.121+5655%0.041-95%
Usd Book Value---33766000.000-33702249.7500%714250.000-4827%132127850.050-126%136865000.025-125%
Usd Book Value Change Per Share--0.002-0.037+1788%-0.059+2790%-0.121+5655%-0.015+777%
Usd Book Value Per Share---0.223-0.224+0%0.005-4810%0.877-125%0.908-125%
Usd Dividend Per Share----0%-0%-0%0.056-100%
Usd Eps---0.021-0.134+543%-0.250+1098%-0.294+1306%-0.275+1214%
Usd Free Cash Flow---9516000.000-11181500.000+18%-32219500.000+239%-34858500.000+266%-34623825.000+264%
Usd Free Cash Flow Per Share---0.063-0.074+18%-0.214+240%-0.231+268%-0.230+265%
Usd Free Cash Flow To Equity Per Share---0.0630.016-493%-0.089+41%-0.074+18%0.001-10198%
Usd Market Cap417308787.8400%418821230.000251215342.220+67%415048992.960+1%1491351926.668-72%2276574004.790-82%
Usd Price Per Share2.7700%2.7701.665+66%2.755+1%9.899-72%15.111-82%
Usd Profit---3160000.000-20237750.000+540%-41209000.000+1204%-45016900.000+1325%-41730925.000+1221%
Usd Revenue--34670000.00033024750.000+5%28457500.000+22%27936800.000+24%17512975.000+98%
Usd Total Gains Per Share--0.002-0.037+1788%-0.059+2790%-0.121+5655%0.041-95%
 EOD+0 -2MRQTTM+28 -4YOY+28 -55Y+24 -910Y+19 -16

4.2. Fundamental Score

Let's check the fundamental score of Heron Therapeuti based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-33.135
Price to Book Ratio (EOD)Between0-1-12.404
Net Profit Margin (MRQ)Greater than0-0.091
Operating Margin (MRQ)Greater than0-0.138
Quick Ratio (MRQ)Greater than12.493
Current Ratio (MRQ)Greater than12.466
Debt to Asset Ratio (MRQ)Less than11.155
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.015
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Heron Therapeuti based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.918
Ma 20Greater thanMa 503.395
Ma 50Greater thanMa 1003.173
Ma 100Greater thanMa 2002.956
OpenGreater thanClose2.750
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets217,887
Total Liabilities251,653
Total Stockholder Equity-33,766
 As reported
Total Liabilities 251,653
Total Stockholder Equity+ -33,766
Total Assets = 217,887

Assets

Total Assets217,887
Total Current Assets185,903
Long-term Assets31,984
Total Current Assets
Cash And Cash Equivalents 20,450
Short-term Investments 51,074
Net Receivables 65,322
Inventory 42,473
Other Current Assets 6,584
Total Current Assets  (as reported)185,903
Total Current Assets  (calculated)185,903
+/-0
Long-term Assets
Property Plant Equipment 24,100
Long-term Assets Other 7,884
Long-term Assets  (as reported)31,984
Long-term Assets  (calculated)31,984
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities75,378
Long-term Liabilities176,275
Total Stockholder Equity-33,766
Total Current Liabilities
Short-term Debt 3,137
Accounts payable 837
Other Current Liabilities 71,404
Total Current Liabilities  (as reported)75,378
Total Current Liabilities  (calculated)75,378
+/-0
Long-term Liabilities
Long term Debt 173,989
Capital Lease Obligations Min Short Term Debt2,045
Long-term Liabilities Other 241
Long-term Liabilities  (as reported)176,275
Long-term Liabilities  (calculated)176,275
+/- 0
Total Stockholder Equity
Common Stock1,504
Retained Earnings -1,909,174
Accumulated Other Comprehensive Income -6
Other Stockholders Equity 1,873,910
Total Stockholder Equity (as reported)-33,766
Total Stockholder Equity (calculated)-33,766
+/-0
Other
Capital Stock1,504
Cash and Short Term Investments 71,524
Common Stock Shares Outstanding 151,199
Liabilities and Stockholders Equity 217,887
Net Debt 158,721
Net Invested Capital 140,223
Net Working Capital 110,525
Property Plant and Equipment Gross 24,100
Short Long Term Debt Total 179,171



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-311992-12-311992-09-301992-06-301992-03-311991-12-311991-09-301991-06-301991-03-311990-12-311990-09-301990-06-301990-03-311989-12-311989-09-301989-06-301989-03-311988-12-311988-09-301988-06-301988-03-311987-12-311987-09-301987-06-301987-03-31
> Total Assets 
0
0
0
21,000
0
0
0
16,800
0
15,400
14,400
13,200
12,300
11,900
10,700
11,600
10,200
10,000
9,100
9,600
20,500
24,500
29,900
28,300
26,400
31,700
25,800
24,400
27,900
30,100
25,800
23,500
27,900
25,800
26,800
23,100
24,600
25,400
23,500
18,400
19,600
21,000
22,400
24,200
24,600
24,400
23,700
23,100
24,900
23,700
23,700
23,500
22,488
18,646
29,007
26,996
25,068
23,923
24,774
23,507
21,692
20,465
18,913
17,799
18,077
15,909
14,679
13,155
11,267
20,054
18,579
17,014
14,899
12,871
11,232
8,969
27,846
23,496
19,949
17,251
10,962
46,712
41,636
36,950
29,673
23,427
18,057
11,800
8,637
4,792
3,037
8,951
8,805
6,852
4,089
2,911
1,865
22,121
21,796
19,445
14,994
14,231
61,761
55,972
48,979
38,090
26,370
75,937
62,793
108,638
92,282
76,682
59,627
176,456
158,151
137,845
111,846
85,731
98,806
67,482
189,558
142,370
118,196
234,307
183,383
510,556
470,896
462,179
435,794
411,666
392,962
512,782
478,941
432,721
390,023
353,556
310,932
404,250
352,388
305,706
273,723
243,965
271,952
250,951
220,878
201,224
229,199
222,506
217,887
217,887222,506229,199201,224220,878250,951271,952243,965273,723305,706352,388404,250310,932353,556390,023432,721478,941512,782392,962411,666435,794462,179470,896510,556183,383234,307118,196142,370189,55867,48298,80685,731111,846137,845158,151176,45659,62776,68292,282108,63862,79375,93726,37038,09048,97955,97261,76114,23114,99419,44521,79622,1211,8652,9114,0896,8528,8058,9513,0374,7928,63711,80018,05723,42729,67336,95041,63646,71210,96217,25119,94923,49627,8468,96911,23212,87114,89917,01418,57920,05411,26713,15514,67915,90918,07717,79918,91320,46521,69223,50724,77423,92325,06826,99629,00718,64622,48823,50023,70023,70024,90023,10023,70024,40024,60024,20022,40021,00019,60018,40023,50025,40024,60023,10026,80025,80027,90023,50025,80030,10027,90024,40025,80031,70026,40028,30029,90024,50020,5009,6009,10010,00010,20011,60010,70011,90012,30013,20014,40015,400016,80000021,000000
   > Total Current Assets 
0
0
0
16,500
0
0
0
12,300
0
11,000
9,900
8,800
8,000
7,700
6,600
6,200
5,000
4,900
4,200
4,700
13,000
16,600
21,400
19,100
17,200
22,200
16,300
15,100
18,400
20,700
16,600
16,400
20,900
19,100
19,800
16,500
17,200
18,200
16,400
11,700
12,900
13,800
14,800
15,200
14,800
14,200
13,400
12,800
14,900
13,600
13,500
13,800
13,120
16,536
26,974
25,050
23,186
22,045
22,949
21,624
19,913
18,480
16,980
15,974
16,069
13,927
12,753
11,258
9,631
18,406
16,985
15,496
13,523
11,579
9,839
7,648
26,612
22,354
18,891
16,206
10,009
45,837
40,767
35,796
28,386
22,161
16,894
10,816
7,746
3,980
2,313
8,313
8,222
6,400
3,629
2,501
1,503
21,830
21,320
18,240
13,750
12,999
60,403
54,090
46,149
35,209
23,360
72,925
59,737
105,530
89,242
73,732
56,501
173,421
154,995
134,751
108,201
81,130
93,974
62,143
183,615
136,353
112,590
228,063
176,563
502,624
460,062
447,248
406,205
380,835
364,147
479,064
438,448
392,895
350,995
314,196
272,288
366,826
315,052
254,423
222,593
194,209
223,804
205,435
178,159
165,280
193,979
188,774
185,903
185,903188,774193,979165,280178,159205,435223,804194,209222,593254,423315,052366,826272,288314,196350,995392,895438,448479,064364,147380,835406,205447,248460,062502,624176,563228,063112,590136,353183,61562,14393,97481,130108,201134,751154,995173,42156,50173,73289,242105,53059,73772,92523,36035,20946,14954,09060,40312,99913,75018,24021,32021,8301,5032,5013,6296,4008,2228,3132,3133,9807,74610,81616,89422,16128,38635,79640,76745,83710,00916,20618,89122,35426,6127,6489,83911,57913,52315,49616,98518,4069,63111,25812,75313,92716,06915,97416,98018,48019,91321,62422,94922,04523,18625,05026,97416,53613,12013,80013,50013,60014,90012,80013,40014,20014,80015,20014,80013,80012,90011,70016,40018,20017,20016,50019,80019,10020,90016,40016,60020,70018,40015,10016,30022,20017,20019,10021,40016,60013,0004,7004,2004,9005,0006,2006,6007,7008,0008,8009,90011,000012,30000016,500000
       Cash And Cash Equivalents 
0
0
0
15,900
0
0
0
11,400
0
9,500
8,700
2,600
3,100
3,300
4,100
1,700
2,400
2,400
1,400
1,600
4,800
4,400
7,000
2,700
2,100
400
1,100
1,800
2,800
7,300
6,000
2,700
4,200
2,200
6,100
5,200
5,500
7,500
7,300
5,400
5,400
7,400
8,500
8,700
6,400
5,200
3,400
4,100
5,400
3,500
3,500
3,700
3,539
2,671
9,904
6,493
4,797
4,156
2,627
3,618
4,802
1,844
6,556
3,282
3,632
1,245
1,473
97
2,400
5,813
673
3,110
354
1,972
2,281
790
10,970
5,943
3,769
2,333
1,005
40,710
37,873
33,510
26,503
20,356
15,680
9,967
7,110
3,610
1,569
7,593
7,562
5,736
3,015
2,109
1,085
21,331
21,019
17,974
13,444
12,442
60,048
53,506
45,722
34,849
22,597
72,287
57,475
105,012
86,212
72,675
55,556
171,526
152,989
75,180
68,016
61,943
45,640
13,414
83,513
30,277
65,524
144,583
46,575
258,934
53,934
31,836
23,461
53,038
60,108
71,898
103,285
80,728
95,141
105,138
59,739
191,173
159,570
90,541
56,911
48,609
50,438
15,364
27,090
13,462
34,859
28,677
20,450
20,45028,67734,85913,46227,09015,36450,43848,60956,91190,541159,570191,17359,739105,13895,14180,728103,28571,89860,10853,03823,46131,83653,934258,93446,575144,58365,52430,27783,51313,41445,64061,94368,01675,180152,989171,52655,55672,67586,212105,01257,47572,28722,59734,84945,72253,50660,04812,44213,44417,97421,01921,3311,0852,1093,0155,7367,5627,5931,5693,6107,1109,96715,68020,35626,50333,51037,87340,7101,0052,3333,7695,94310,9707902,2811,9723543,1106735,8132,400971,4731,2453,6323,2826,5561,8444,8023,6182,6274,1564,7976,4939,9042,6713,5393,7003,5003,5005,4004,1003,4005,2006,4008,7008,5007,4005,4005,4007,3007,5005,5005,2006,1002,2004,2002,7006,0007,3002,8001,8001,1004002,1002,7007,0004,4004,8001,6001,4002,4002,4001,7004,1003,3003,1002,6008,7009,500011,40000015,900000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,899
16,029
16,252
15,882
16,619
15,876
13,238
14,482
8,568
10,839
10,836
10,830
9,620
9,387
5,344
10,844
14,574
10,486
11,426
7,775
5,810
5,019
15,202
15,729
14,304
13,189
8,357
4,364
1,916
1,552
1,331
1,164
859
571
374
194
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,986
32,391
12,700
43,279
37,724
81,703
78,986
8,492
27,796
67,363
164,030
310,866
300,535
265,777
222,967
196,170
319,074
253,061
220,114
163,005
103,353
106,727
66,505
43,250
67,039
54,999
34,929
71,308
69,488
32,932
19,782
42,553
51,732
51,074
51,07451,73242,55319,78232,93269,48871,30834,92954,99967,03943,25066,505106,727103,353163,005220,114253,061319,074196,170222,967265,777300,535310,866164,03067,36327,7968,49278,98681,70337,72443,27912,70032,39155,986000000000000000000000000391943745718591,1641,3311,5521,9164,3648,35713,18914,30415,72915,2025,0195,8107,77511,42610,48614,57410,8445,3449,3879,62010,83010,83610,8398,56814,48213,23815,87616,61915,88216,25216,02913,899000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
600
0
0
0
700
0
600
600
700
500
900
1,000
1,000
800
600
900
1,200
600
800
500
1,600
1,800
5,300
2,300
2,800
4,300
5,200
2,100
1,900
3,400
4,700
3,500
2,500
4,100
4,300
3,100
1,700
2,800
3,300
3,200
3,400
4,800
5,300
5,900
4,800
5,300
5,300
5,300
5,100
4,344
5,610
2,485
1,691
1,413
1,262
2,848
1,468
1,469
1,471
1,378
1,505
1,386
1,341
1,267
1,340
1,466
1,287
1,238
1,506
1,435
1,393
1,413
1,519
75
75
75
75
125
139
125
152
133
152
32
32
8
11
486
171
224
356
328
110
261
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
45
0
0
0
1,960
10,327
18,616
28,851
41,874
37,713
45,886
53,633
64,652
74,007
66,821
66,955
39,879
34,811
37,502
33,654
41,850
38,525
42,615
43,086
35,499
41,103
40,303
42,188
52,049
51,448
76,693
63,795
60,137
65,322
65,32260,13763,79576,69351,44852,04942,18840,30341,10335,49943,08642,61538,52541,85033,65437,50234,81139,87966,95566,82174,00764,65253,63345,88637,71341,87428,85118,61610,3271,9600004500000000000000000282611103283562241714861183232152133152125139125757575751,5191,4131,3931,4351,5061,2381,2871,4661,3401,2671,3411,3861,5051,3781,4711,4691,4682,8481,2621,4131,6912,4855,6104,3445,1005,3005,3005,3004,8005,9005,3004,8003,4003,2003,3002,8001,7003,1004,3004,1002,5003,5004,7003,4001,9002,1005,2004,3002,8002,3005,3001,8001,6005008006001,2009006008001,0001,0009005007006006000700000600000
       Other Current Assets 
0
0
0
0
0
0
0
100
0
800
400
5,400
4,200
3,300
1,200
3,200
1,600
1,600
1,700
1,400
6,800
10,300
12,300
13,400
11,300
8,500
5,000
2,100
2,100
1,000
1,600
4,800
4,300
3,800
1,700
900
1,000
1,000
900
2,500
2,000
500
400
500
600
600
1,300
900
1,000
1,200
1,100
400
484
8,174
619
765
19
665
770
601
353
628
412
280
215
511
393
434
421
462
500
394
308
439
335
320
365
607
743
609
522
624
853
582
419
489
323
246
254
165
219
549
436
308
286
282
157
499
301
266
306
557
355
584
427
360
763
638
2,262
518
3,030
1,057
945
1,895
2,006
3,585
5,050
3,175
3,072
3,705
3,431
3,673
4,554
3,702
5,494
6,577
10,217
11,193
11,539
8,739
16,742
23,245
12,442
13,109
16,446
21,950
24,668
23,733
27,644
12,962
13,110
9,050
7,631
13,961
14,630
10,720
10,765
6,118
6,584
6,5846,11810,76510,72014,63013,9617,6319,05013,11012,96227,64423,73324,66821,95016,44613,10912,44223,24516,7428,73911,53911,19310,2176,5775,4943,7024,5543,6733,4313,7053,0723,1755,0503,5852,0061,8959451,0573,0305182,262638763360427584355557306266301499157282286308436549219165254246323489419582853624522609743607365320335439308394500462421434393511215280412628353601770665197656198,1744844001,1001,2001,0009001,3006006005004005002,0002,5009001,0001,0009001,7003,8004,3004,8001,6001,0002,1002,1005,0008,50011,30013,40012,30010,3006,8001,4001,7001,6001,6003,2001,2003,3004,2005,40040080001000000000
   > Long-term Assets 
0
0
0
4,500
0
0
0
4,500
0
4,400
4,500
4,400
4,300
4,200
4,100
5,400
5,200
5,100
4,900
4,900
7,500
7,900
8,500
9,200
9,200
9,500
9,500
9,300
9,500
9,400
9,200
7,100
7,000
6,700
7,000
6,600
7,400
7,200
7,100
6,700
6,700
7,200
7,600
9,000
9,800
10,200
10,300
10,300
10,000
10,100
10,200
9,700
9,368
2,111
2,032
1,946
1,882
1,878
1,825
1,883
1,779
1,985
1,933
1,825
2,008
1,982
1,926
1,897
1,636
1,648
1,594
1,518
1,376
1,292
1,393
1,321
1,234
1,142
1,058
1,045
953
875
869
1,154
1,287
1,266
1,163
984
891
812
724
638
583
452
460
410
362
291
476
1,205
1,244
1,232
1,358
1,882
2,830
2,881
3,010
3,012
3,056
3,108
3,040
2,950
3,126
3,035
3,156
3,094
3,645
4,601
4,832
5,339
5,943
6,017
5,606
6,244
6,820
7,932
10,834
14,931
29,589
30,831
28,815
33,718
40,493
39,826
39,028
39,360
38,644
37,424
37,336
51,283
51,130
49,756
48,148
45,516
42,719
35,944
35,220
33,732
31,984
31,98433,73235,22035,94442,71945,51648,14849,75651,13051,28337,33637,42438,64439,36039,02839,82640,49333,71828,81530,83129,58914,93110,8347,9326,8206,2445,6066,0175,9435,3394,8324,6013,6453,0943,1563,0353,1262,9503,0403,1083,0563,0123,0102,8812,8301,8821,3581,2321,2441,2054762913624104604525836387248128919841,1631,2661,2871,1548698759531,0451,0581,1421,2341,3211,3931,2921,3761,5181,5941,6481,6361,8971,9261,9822,0081,8251,9331,9851,7791,8831,8251,8781,8821,9462,0322,1119,3689,70010,20010,10010,00010,30010,30010,2009,8009,0007,6007,2006,7006,7007,1007,2007,4006,6007,0006,7007,0007,1009,2009,4009,5009,3009,5009,5009,2009,2008,5007,9007,5004,9004,9005,1005,2005,4004,1004,2004,3004,4004,5004,40004,5000004,500000
       Property Plant Equipment 
0
0
0
4,200
0
0
0
4,300
0
4,400
4,400
4,300
4,200
4,100
4,000
3,800
3,700
3,500
3,300
3,200
4,300
4,800
5,400
4,900
5,200
5,500
5,600
5,400
5,300
5,300
5,200
5,100
5,100
4,900
4,700
5,000
4,800
4,700
4,800
4,700
4,600
4,900
5,400
6,800
7,800
8,400
8,600
8,600
8,500
8,300
8,300
8,000
7,838
1,855
1,875
1,795
1,731
1,727
1,674
1,668
1,570
1,782
1,736
1,636
1,527
1,505
1,454
1,430
1,349
1,366
1,313
1,235
1,167
1,115
1,219
1,164
1,095
1,020
953
958
883
800
794
1,079
1,212
1,163
1,060
881
788
684
596
510
455
399
407
357
309
263
346
1,075
1,114
1,102
1,228
1,752
2,700
2,733
2,857
2,882
2,926
2,978
2,910
2,820
2,996
2,905
2,982
3,049
3,645
4,471
4,702
5,076
5,680
5,754
5,343
5,981
6,504
7,505
10,581
14,677
29,335
30,577
28,561
33,372
40,147
39,480
38,682
39,014
38,298
37,078
36,990
33,563
33,153
32,222
30,823
29,805
28,583
27,361
26,854
25,604
24,100
24,10025,60426,85427,36128,58329,80530,82332,22233,15333,56336,99037,07838,29839,01438,68239,48040,14733,37228,56130,57729,33514,67710,5817,5056,5045,9815,3435,7545,6805,0764,7024,4713,6453,0492,9822,9052,9962,8202,9102,9782,9262,8822,8572,7332,7001,7521,2281,1021,1141,0753462633093574073994555105966847888811,0601,1631,2121,0797948008839589531,0201,0951,1641,2191,1151,1671,2351,3131,3661,3491,4301,4541,5051,5271,6361,7361,7821,5701,6681,6741,7271,7311,7951,8751,8557,8388,0008,3008,3008,5008,6008,6008,4007,8006,8005,4004,9004,6004,7004,8004,7004,8005,0004,7004,9005,1005,1005,2005,3005,3005,4005,6005,5005,2004,9005,4004,8004,3003,2003,3003,5003,7003,8004,0004,1004,2004,3004,4004,40004,3000004,200000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
800
800
700
700
600
600
500
500
500
400
400
300
900
300
200
200
1,500
1,400
1,300
100
1,400
1,600
1,600
1,500
1,500
1,400
1,400
1,400
1,300
1,300
1,300
1,300
1,207
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001,2071,3001,3001,3001,3001,4001,4001,4001,5001,5001,6001,6001,4001001,3001,4001,50020020030090030040040050050050060060070070080080000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,530
256
157
151
151
151
151
215
209
203
197
189
481
477
472
467
287
282
281
283
209
177
174
157
139
122
105
87
70
75
75
75
75
103
103
103
103
128
128
128
128
53
53
53
53
28
130
130
130
130
130
130
130
148
153
130
130
130
130
130
130
130
174
45
0
130
130
263
263
263
263
263
316
427
253
254
254
254
254
346
346
346
346
16,623
346
346
346
17,720
17,977
17,534
17,325
15,711
0
8,583
8,366
0
0
008,3668,583015,71117,32517,53417,97717,72034634634616,62334634634634625425425425425342731626326326326326313013004517413013013013013013013015314813013013013013013013028535353531281281281281031031031037575757570871051221391571741772092832812822874674724774811891972032092151511511511511572561,5300000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
3,800
0
0
0
3,500
0
3,800
3,700
3,700
3,700
3,800
3,800
5,300
5,000
5,100
5,100
6,400
5,200
6,100
8,200
8,100
7,900
15,800
12,400
13,900
17,200
15,900
12,900
11,700
15,400
14,900
17,400
17,900
15,900
16,000
15,900
13,400
13,900
14,000
13,900
14,000
12,600
11,800
10,500
8,600
9,800
8,100
13,200
11,500
10,049
6,701
6,403
5,837
4,767
4,771
3,991
4,335
3,585
3,775
3,266
2,340
2,564
2,301
2,102
1,892
2,519
1,833
2,252
2,860
1,956
2,430
2,507
2,766
2,218
2,301
2,420
5,192
4,735
4,553
4,558
7,476
6,725
6,246
6,763
4,202
3,764
3,414
2,555
2,155
2,210
2,846
1,558
1,595
1,729
3,229
2,604
3,693
3,361
3,116
4,244
4,154
7,596
9,592
5,498
6,992
7,384
10,792
11,274
13,620
11,626
16,590
16,450
19,735
19,170
27,890
80,926
88,733
87,398
73,295
78,143
103,171
91,177
78,665
64,088
92,019
103,980
106,307
107,520
108,947
113,473
108,663
112,876
117,064
114,707
244,138
233,545
228,136
249,765
265,701
249,502
237,379
232,307
240,508
256,985
256,479
251,653
251,653256,479256,985240,508232,307237,379249,502265,701249,765228,136233,545244,138114,707117,064112,876108,663113,473108,947107,520106,307103,98092,01964,08878,66591,177103,17178,14373,29587,39888,73380,92627,89019,17019,73516,45016,59011,62613,62011,27410,7927,3846,9925,4989,5927,5964,1544,2443,1163,3613,6932,6043,2291,7291,5951,5582,8462,2102,1552,5553,4143,7644,2026,7636,2466,7257,4764,5584,5534,7355,1922,4202,3012,2182,7662,5072,4301,9562,8602,2521,8332,5191,8922,1022,3012,5642,3403,2663,7753,5854,3353,9914,7714,7675,8376,4036,70110,04911,50013,2008,1009,8008,60010,50011,80012,60014,00013,90014,00013,90013,40015,90016,00015,90017,90017,40014,90015,40011,70012,90015,90017,20013,90012,40015,8007,9008,1008,2006,1005,2006,4005,1005,1005,0005,3003,8003,8003,7003,7003,7003,80003,5000003,800000
   > Total Current Liabilities 
0
0
0
700
0
0
0
600
0
800
700
700
600
3,700
3,800
2,300
2,100
2,100
2,100
2,400
1,200
2,100
4,200
4,400
4,300
12,200
8,900
10,500
13,900
12,700
9,800
10,700
14,400
14,200
12,000
11,500
9,700
10,000
9,700
7,900
8,900
9,700
10,200
10,900
12,200
11,700
9,000
7,500
5,600
4,200
4,800
4,400
3,830
3,957
5,468
4,963
3,910
4,039
3,141
3,549
2,800
2,940
2,505
1,995
2,419
2,156
2,027
1,892
2,519
1,833
2,252
2,860
1,956
2,430
2,507
2,766
2,218
2,301
2,420
4,192
3,735
3,553
3,558
6,207
5,507
5,115
5,691
3,187
2,764
2,414
2,404
1,887
1,982
2,650
1,369
1,560
1,685
3,204
2,540
3,693
3,361
3,116
4,244
4,154
7,596
9,592
5,498
6,992
7,384
10,792
11,274
13,620
11,626
16,590
16,450
19,735
19,170
27,890
30,926
38,733
37,398
48,295
53,143
103,171
91,177
78,665
64,088
92,019
92,257
95,056
96,737
96,705
96,765
92,651
97,578
102,503
100,917
82,143
72,296
71,058
93,001
109,498
93,876
82,355
77,900
86,722
79,745
79,685
75,378
75,37879,68579,74586,72277,90082,35593,876109,49893,00171,05872,29682,143100,917102,50397,57892,65196,76596,70596,73795,05692,25792,01964,08878,66591,177103,17153,14348,29537,39838,73330,92627,89019,17019,73516,45016,59011,62613,62011,27410,7927,3846,9925,4989,5927,5964,1544,2443,1163,3613,6932,5403,2041,6851,5601,3692,6501,9821,8872,4042,4142,7643,1875,6915,1155,5076,2073,5583,5533,7354,1922,4202,3012,2182,7662,5072,4301,9562,8602,2521,8332,5191,8922,0272,1562,4191,9952,5052,9402,8003,5493,1414,0393,9104,9635,4683,9573,8304,4004,8004,2005,6007,5009,00011,70012,20010,90010,2009,7008,9007,9009,70010,0009,70011,50012,00014,20014,40010,7009,80012,70013,90010,5008,90012,2004,3004,4004,2002,1001,2002,4002,1002,1002,1002,3003,8003,7006007007008000600000700000
       Short-term Debt 
0
0
0
100
0
0
0
0
0
0
0
0
0
3,000
3,000
0
0
0
0
0
0
0
0
300
300
300
300
300
300
300
300
2,200
2,200
2,100
700
900
1,500
2,300
2,700
800
1,800
2,200
2,500
2,500
4,600
4,200
3,700
3,100
1,200
1,000
1,000
900
922
955
0
0
3,083
2,730
0
1,409
992
0
1,246
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
1,000
0
0
0
0
0
0
0
0
0
103
143
239
365
492
622
754
888
1,025
1,164
1,306
1,450
1,598
1,749
1,903
2,061
2,222
2,388
2,558
2,732
2,911
3,096
3,285
3,481
28,684
28,894
29,112
4,338
4,574
6,853
6,803
7,075
7,550
8,689
9,099
9,549
10,050
10,636
3,162
3,251
2,417
2,484
2,549
2,620
2,694
2,762
2,580
2,999
3,075
3,137
3,1373,0752,9992,5802,7622,6942,6202,5492,4842,4173,2513,16210,63610,0509,5499,0998,6897,5507,0756,8036,8534,5744,33829,11228,89428,6843,4813,2853,0962,9112,7322,5582,3882,2222,0611,9031,7491,5981,4501,3061,1641,0258887546224923652391431030000000001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,00000000000000000001,24609921,40902,7303,083009559229001,0001,0001,2003,1003,7004,2004,6002,5002,5002,2001,8008002,7002,3001,5009007002,1002,2002,200300300300300300300300300000000003,0003,000000000000100000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,598
0
0
0
2,222
0
0
0
52,911
3,096
28,285
28,481
25,000
25,000
25,000
0
0
4,821
5,081
5,354
5,624
5,934
6,269
6,637
7,053
7,555
0
0
0
0
0
0
0
0
0
0
0
0
0000000000007,5557,0536,6376,2695,9345,6245,3545,0814,8210025,00025,00025,00028,48128,2853,09652,9110002,2220001,598000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
300
300
300
200
400
500
400
100
200
200
400
300
700
300
600
600
1,900
1,300
7,300
2,900
10,200
7,200
6,200
9,600
9,500
8,900
7,500
5,100
4,600
1,200
2,300
1,200
900
1,600
1,600
1,700
1,300
1,200
1,300
1,300
1,100
1,100
1,000
907
1,688
702
329
185
667
653
347
136
341
244
286
182
377
295
476
1,201
374
701
697
553
626
943
614
388
147
357
772
577
717
500
1,437
1,390
1,285
715
344
689
554
231
162
241
128
157
159
309
289
433
1,010
890
605
1,758
1,912
3,825
5,350
2,250
1,264
3,603
1,769
1,475
3,435
2,383
2,987
2,735
3,336
6,861
8,661
6,090
7,853
4,477
6,315
5,337
18,917
11,458
4,979
9,644
17,087
10,811
7,997
1,627
2,758
11,562
18,458
12,067
525
1,689
11,242
5,885
3,803
8,226
13,804
6,547
3,225
4,065
1,957
1,860
3,240
837
8373,2401,8601,9574,0653,2256,54713,8048,2263,8035,88511,2421,68952512,06718,45811,5622,7581,6277,99710,81117,0879,6444,97911,45818,9175,3376,3154,4777,8536,0908,6616,8613,3362,7352,9872,3833,4351,4751,7693,6031,2642,2505,3503,8251,9121,7586058901,0104332893091591571282411622315546893447151,2851,3901,4375007175777723571473886149436265536977013741,2014762953771822862443411363476536671853297021,6889071,0001,1001,1001,3001,3001,2001,3001,7001,6001,6009001,2002,3001,2004,6005,1007,5008,9009,5009,6006,2007,20010,2002,9007,3001,3001,900600600300700300400200200100400500400200300300300000000000
       Other Current Liabilities 
0
0
0
600
0
0
0
600
0
500
400
400
400
300
300
1,900
2,000
1,900
1,900
2,000
900
1,400
3,900
3,500
3,400
10,000
7,300
2,900
10,700
2,200
2,300
2,300
2,600
2,600
2,400
3,100
3,100
3,100
5,800
4,800
5,900
6,600
6,100
6,800
5,900
6,200
4,100
3,100
3,100
2,100
2,700
2,500
2,000
1,314
4,766
4,633
237
237
2,083
1,479
1,347
2,334
750
1,459
1,787
1,305
1,405
1,226
1,128
1,283
1,551
2,163
1,403
1,804
1,564
2,152
1,830
2,154
2,063
3,420
3,158
2,836
3,058
4,770
4,117
3,830
4,976
2,843
2,075
1,860
1,953
1,633
1,626
2,410
1,117
1,164
1,164
2,915
2,107
388
2,471
2,272
2,486
1,750
3,149
3,488
2,360
4,703
2,617
7,717
8,349
8,587
7,494
11,700
11,654
14,177
9,921
16,671
22,104
26,870
24,590
33,907
38,765
52,807
50,825
44,574
50,106
70,358
74,593
80,256
88,035
86,087
76,514
65,094
75,962
91,824
88,592
67,739
63,160
62,421
82,291
93,145
84,709
76,436
71,073
82,185
74,886
73,370
71,404
71,40473,37074,88682,18571,07376,43684,70993,14582,29162,42163,16067,73988,59291,82475,96265,09476,51486,08788,03580,25674,59370,35850,10644,57450,82552,80738,76533,90724,59026,87022,10416,6719,92114,17711,65411,7007,4948,5878,3497,7172,6174,7032,3603,4883,1491,7502,4862,2722,4713882,1072,9151,1641,1641,1172,4101,6261,6331,9531,8602,0752,8434,9763,8304,1174,7703,0582,8363,1583,4202,0632,1541,8302,1521,5641,8041,4032,1631,5511,2831,1281,2261,4051,3051,7871,4597502,3341,3471,4792,0832372374,6334,7661,3142,0002,5002,7002,1003,1003,1004,1006,2005,9006,8006,1006,6005,9004,8005,8003,1003,1003,1002,4002,6002,6002,3002,3002,20010,7002,9007,30010,0003,4003,5003,9001,4009002,0001,9001,9002,0001,9003003004004004005000600000600000
   > Long-term Liabilities 
0
0
0
3,100
0
0
0
2,900
0
3,000
3,000
3,000
3,100
100
0
3,000
2,900
3,000
3,000
4,000
4,000
4,000
4,000
3,700
3,600
3,600
3,500
3,400
3,300
3,200
3,100
1,000
1,000
700
5,400
6,400
6,200
6,000
6,200
5,500
5,000
4,300
3,700
3,100
400
100
1,500
1,100
4,200
3,900
8,400
7,100
6,219
2,745
936
874
857
732
849
785
785
835
761
345
145
145
75
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
1,269
1,218
1,131
1,072
1,015
1,000
1,000
151
268
228
196
189
35
44
25
64
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
50,000
50,000
25,000
25,000
0
0
0
0
0
11,723
11,251
10,783
12,242
16,708
16,012
15,298
14,561
13,790
161,995
161,249
157,078
156,764
156,203
155,626
155,024
154,407
153,786
177,240
176,794
176,275
176,275176,794177,240153,786154,407155,024155,626156,203156,764157,078161,249161,99513,79014,56115,29816,01216,70812,24210,78311,25111,7230000025,00025,00050,00050,00050,0000000000000000000000642544351891962282681511,0001,0001,0151,0721,1311,2181,2691,0001,0001,0001,000000000000000751451453457618357857858497328578749362,7456,2197,1008,4003,9004,2001,1001,5001004003,1003,7004,3005,0005,5006,2006,0006,2006,4005,4007001,0001,0003,1003,2003,3003,4003,5003,6003,6003,7004,0004,0004,0004,0003,0003,0002,9003,00001003,1003,0003,0003,00002,9000003,100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25
64
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,982
149,032
149,082
149,132
149,182
149,234
0
149,335
149,387
0
0
0
000149,387149,3350149,234149,182149,132149,082149,032148,9820000000000000000000000000000000000000064250000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,053
830
935
874
857
732
849
786
785
835
761
345
145
145
75
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
1,269
1,218
1,131
1,072
1,015
1,000
1,000
151
268
228
196
189
35
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
50,000
25,000
25,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
241
241
241
241
0
241
241
0
0
0024124102412412412410000000000000000025,00025,00050,00050,000000000000000000000000044351891962282681511,0001,0001,0151,0721,1311,2181,2691,0001,0001,0001,000000000000000751451453457618357857868497328578749358304,0530000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
17,200
0
0
0
13,300
0
11,600
10,700
9,500
8,600
8,100
6,900
6,300
5,200
4,700
3,800
3,100
15,300
18,400
21,700
20,200
18,500
15,900
13,400
10,500
10,700
14,200
12,900
11,800
12,500
10,900
9,400
5,200
8,700
9,400
7,600
5,000
5,700
7,000
8,500
10,200
12,000
12,600
13,200
14,500
15,100
15,600
10,500
12,000
12,439
11,945
22,603
21,159
20,301
19,152
20,784
19,172
18,107
16,690
15,647
15,459
15,513
13,608
12,577
11,263
8,748
18,221
16,327
14,154
12,943
10,441
8,725
6,203
25,628
21,195
17,529
12,059
6,227
42,159
37,078
29,474
22,948
17,181
11,294
7,598
4,873
1,378
482
6,796
6,595
4,006
2,531
1,316
136
18,892
19,192
15,752
11,633
11,115
57,517
51,818
41,383
28,498
20,872
68,945
55,409
97,846
81,008
63,062
48,001
159,866
141,701
118,110
92,676
57,841
17,880
-21,251
102,160
69,075
40,053
131,136
92,206
431,891
406,808
370,160
331,814
305,359
285,442
403,835
365,468
324,058
277,147
236,492
196,225
160,112
118,843
77,570
23,958
-21,736
22,450
13,572
-11,429
-39,284
-27,786
-33,973
-33,766
-33,766-33,973-27,786-39,284-11,42913,57222,450-21,73623,95877,570118,843160,112196,225236,492277,147324,058365,468403,835285,442305,359331,814370,160406,808431,89192,206131,13640,05369,075102,160-21,25117,88057,84192,676118,110141,701159,86648,00163,06281,00897,84655,40968,94520,87228,49841,38351,81857,51711,11511,63315,75219,19218,8921361,3162,5314,0066,5956,7964821,3784,8737,59811,29417,18122,94829,47437,07842,1596,22712,05917,52921,19525,6286,2038,72510,44112,94314,15416,32718,2218,74811,26312,57713,60815,51315,45915,64716,69018,10719,17220,78419,15220,30121,15922,60311,94512,43912,00010,50015,60015,10014,50013,20012,60012,00010,2008,5007,0005,7005,0007,6009,4008,7005,2009,40010,90012,50011,80012,90014,20010,70010,50013,40015,90018,50020,20021,70018,40015,3003,1003,8004,7005,2006,3006,9008,1008,6009,50010,70011,600013,30000017,200000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85,300
85,300
200
85,714
85,853
85,954
202
86,365
203
203
204
86,456
86,537
86,567
205
86,646
86,716
86,762
206
86,936
98,865
98,895
250
99,031
99,137
99,170
253
99,404
99,533
99,651
254
99,998
137,700
137,325
307
137,769
138,135
138,463
309
138,906
139,337
139,650
394
395
401
401
401
401
401
2,002
2,002
2,002
2,004
3,024
3,024
3,058
3,060
3,110
237
239
289
292
292
296
356
359
361
363
390
391
394
537
539
546
646
650
775
780
782
789
798
800
903
906
908
909
913
914
1,019
1,019
1,020
1,021
1,025
1,188
1,191
1,193
1,199
1,411
1,503
1,504
1,5041,5031,4111,1991,1931,1911,1881,0251,0211,0201,0191,0199149139099089069038007987897827807756506465465395373943913903633613593562962922922892392373,1103,0603,0583,0243,0242,0042,0022,0022,002401401401401401395394139,650139,337138,906309138,463138,135137,769307137,325137,70099,99825499,65199,53399,40425399,17099,13799,03125098,89598,86586,93620686,76286,71686,64620586,56786,53786,45620420320386,36520285,95485,85385,71420085,30085,3000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity000-1,870,282-1,828,2230-1,775,586-1,733,678-1,677,319-1,613,431-1,558,785-1,506,377-1,445,362-1,392,748-1,330,467-1,272,239-1,217,049-1,165,470-1,107,550-1,073,955-1,023,733-960,721-911,162-872,816-834,147-783,455-720,965-679,099-636,300-585,971-538,008-489,499-446,273-412,828-381,586-358,914-335,807-315,237-294,613-275,419-256,408-238,870-224,827-211,954-196,540-183,587-175,850-169,729-165,160-160,239-155,978-151,7760000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-1,200
0
0
0
-2,300
0
-2,600
-2,600
-2,900
-3,100
-3,300
-3,500
-3,700
-3,900
-4,100
-4,300
-4,400
-4,600
-4,800
-4,800
-5,100
-5,100
-5,100
-5,100
-6,000
-6,000
-6,000
-6,000
-7,000
-6,000
-7,400
-7,700
-7,900
-8,200
-8,400
-8,700
-8,800
-8,800
-9,100
-9,300
-9,500
-8,600
-8,800
-9,100
-9,300
-9,500
-9,700
-9,100
-200
-10,319
-2,948
-2,686
-1
-2,770
-2,770
285
238
114
108
87
76
68
54
35
17
9
-2
-6
-16
-13
-13
-19
-16
-45
-58
-25
-13
-6
-1
-21
-38
-50
-54
-63
-43
-21
-6
0
-4,123
-4,123
0
0
-4,159
-4,159
0
0
-4,283
-4,283
0
0
-4,407
-4,407
0
0
-4,273
-4,273
0
0
-4,833
-4,833
0
0
-40
1
-1
-17
-17
-30
-6
0
-10
-42
-25
-42
-87
36
148
103
85
708
953
540
257
121
41
-4
-6
-8
-11
-57
-19
9
-6
-1
13
-6
-613-1-69-19-57-11-8-6-4411212575409537088510314836-87-42-25-42-100-6-30-17-17-11-4000-4,833-4,83300-4,273-4,27300-4,407-4,40700-4,283-4,28300-4,159-4,15900-4,123-4,1230-6-21-43-63-54-50-38-21-1-6-13-25-58-45-16-19-13-13-16-6-29173554687687108114238285-2,770-2,770-1-2,686-2,948-10,319-200-9,100-9,700-9,500-9,300-9,100-8,800-8,600-9,500-9,300-9,100-8,800-8,800-8,700-8,400-8,200-7,900-7,700-7,400-6,000-7,000-6,000-6,000-6,000-6,000-5,100-5,100-5,100-5,100-4,800-4,800-4,600-4,400-4,300-4,100-3,900-3,700-3,500-3,300-3,100-2,900-2,600-2,6000-2,300000-1,200000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
151,195
173,168
173,989
174,791
178,840
230,343
232,381
234,865
237,392
242,589
307,578
311,578
372,976
375,329
378,007
383,512
518,424
522,928
530,617
538,585
546,951
555,514
564,343
737,953
747,641
760,472
913,955
925,745
1,303,957
1,317,232
1,330,186
1,354,722
1,378,368
1,392,089
1,568,317
1,580,903
1,594,436
1,606,165
1,628,070
1,640,552
1,665,429
1,676,613
1,689,987
1,700,264
1,710,928
1,796,905
0
1,815,592
1,829,805
0
0
0
0001,829,8051,815,59201,796,9051,710,9281,700,2641,689,9871,676,6131,665,4291,640,5521,628,0701,606,1651,594,4361,580,9031,568,3171,392,0891,378,3681,354,7221,330,1861,317,2321,303,957925,745913,955760,472747,641737,953564,343555,514546,951538,585530,617522,928518,424383,512378,007375,329372,976311,578307,578242,589237,392234,865232,381230,343178,840174,791173,989173,168151,1950000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
28,100
0
0
0
30,300
0
31,400
31,400
31,600
31,800
32,700
32,900
33,100
33,400
33,600
34,000
34,900
49,200
53,500
57,700
58,300
58,400
58,400
58,500
59,500
61,600
67,900
69,300
71,600
72,300
74,000
74,800
75,300
81,100
84,100
84,700
85,400
85,700
87,900
90,000
92,000
92,800
93,400
93,800
94,200
94,600
9,700
9,100
95,400
10,319
2,948
2,686
88,670
2,770
89,183
86,268
89,376
3,064
3,059
3,038
86,413
86,646
0
86,762
86,638
0
0
0
98,739
0
99,137
0
98,995
0
0
0
99,581
0
0
0
137,131
137,769
138,135
0
138,383
0
0
0
147,481
147,774
148,762
148,959
153,499
149,579
170,267
173,168
178,272
174,791
178,840
230,343
236,788
234,865
237,392
242,589
311,851
311,578
372,976
375,329
382,840
383,512
518,424
522,928
530,617
538,585
546,951
555,514
564,343
737,953
747,641
760,472
913,955
925,745
1,303,957
1,317,232
1,330,186
1,354,722
1,378,368
1,392,089
1,568,317
1,580,903
1,594,436
1,606,165
1,628,070
1,640,552
1,665,429
1,676,613
1,689,987
1,700,264
1,710,928
1,796,905
1,807,855
1,815,592
1,829,805
1,866,094
1,870,525
1,873,910
1,873,9101,870,5251,866,0941,829,8051,815,5921,807,8551,796,9051,710,9281,700,2641,689,9871,676,6131,665,4291,640,5521,628,0701,606,1651,594,4361,580,9031,568,3171,392,0891,378,3681,354,7221,330,1861,317,2321,303,957925,745913,955760,472747,641737,953564,343555,514546,951538,585530,617522,928518,424383,512382,840375,329372,976311,578311,851242,589237,392234,865236,788230,343178,840174,791178,272173,168170,267149,579153,499148,959148,762147,774147,481000138,3830138,135137,769137,13100099,58100098,995099,137098,73900086,63886,762086,64686,4133,0383,0593,06489,37686,26889,1832,77088,6702,6862,94810,31995,4009,1009,70094,60094,20093,80093,40092,80092,00090,00087,90085,70085,40084,70084,10081,10075,30074,80074,00072,30071,60069,30067,90061,60059,50058,50058,40058,40058,30057,70053,50049,20034,90034,00033,60033,40033,10032,90032,70031,80031,60031,40031,400030,30000028,100000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue127,044
Cost of Revenue-65,105
Gross Profit61,93961,939
 
Operating Income (+$)
Gross Profit61,939
Operating Expense-172,554
Operating Income-110,615-110,615
 
Operating Expense (+$)
Research Development55,897
Selling General Administrative49,014
Selling And Marketing Expenses67,643
Operating Expense172,554172,554
 
Net Interest Income (+$)
Interest Income3,364
Interest Expense-3,868
Other Finance Cost-0
Net Interest Income-504
 
Pretax Income (+$)
Operating Income-110,615
Net Interest Income-504
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-110,559-110,671
EBIT - interestExpense = -114,483
-110,559
-106,691
Interest Expense3,868
Earnings Before Interest and Taxes (EBIT)-110,615-106,691
Earnings Before Interest and Taxes (EBITDA)-107,716
 
After tax Income (+$)
Income Before Tax-110,559
Tax Provision-0
Net Income From Continuing Ops-119,704-110,559
Net Income-110,559
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses237,659
Total Other Income/Expenses Net56504
 

Technical Analysis of Heron Therapeuti
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Heron Therapeuti. The general trend of Heron Therapeuti is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Heron Therapeuti's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Heron Therapeuti.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.9 < 3.93 < 4.15.

The bearish price targets are: 2.3 > 2.27 > 2.16.

Tweet this
Heron Therapeuti Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Heron Therapeuti. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Heron Therapeuti Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Heron Therapeuti. The current macd is -0.0693764.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Heron Therapeuti price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Heron Therapeuti. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Heron Therapeuti price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Heron Therapeuti Daily Moving Average Convergence/Divergence (MACD) ChartHeron Therapeuti Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Heron Therapeuti. The current adx is 22.76.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Heron Therapeuti shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Heron Therapeuti Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Heron Therapeuti. The current sar is 3.615.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Heron Therapeuti Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Heron Therapeuti. The current rsi is 36.92. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Heron Therapeuti Daily Relative Strength Index (RSI) ChartHeron Therapeuti Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Heron Therapeuti. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Heron Therapeuti price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Heron Therapeuti Daily Stochastic Oscillator ChartHeron Therapeuti Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Heron Therapeuti. The current cci is -197.74841686.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Heron Therapeuti Daily Commodity Channel Index (CCI) ChartHeron Therapeuti Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Heron Therapeuti. The current cmo is -37.07564851.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Heron Therapeuti Daily Chande Momentum Oscillator (CMO) ChartHeron Therapeuti Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Heron Therapeuti. The current willr is -93.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Heron Therapeuti Daily Williams %R ChartHeron Therapeuti Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Heron Therapeuti.

Heron Therapeuti Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Heron Therapeuti. The current atr is 0.26160039.

Heron Therapeuti Daily Average True Range (ATR) ChartHeron Therapeuti Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Heron Therapeuti. The current obv is 40,686,523.

Heron Therapeuti Daily On-Balance Volume (OBV) ChartHeron Therapeuti Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Heron Therapeuti. The current mfi is 38.59.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Heron Therapeuti Daily Money Flow Index (MFI) ChartHeron Therapeuti Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Heron Therapeuti.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-05-29MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-31CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-06-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Heron Therapeuti Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Heron Therapeuti based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.918
Ma 20Greater thanMa 503.395
Ma 50Greater thanMa 1003.173
Ma 100Greater thanMa 2002.956
OpenGreater thanClose2.750
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Heron Therapeuti with someone you think should read this too:
  • Are you bullish or bearish on Heron Therapeuti? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Heron Therapeuti? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Heron Therapeuti

I send you an email if I find something interesting about Heron Therapeuti.


Stay informed about Heron Therapeuti.

Receive notifications about Heron Therapeuti in your mailbox!